U.S. Stock News

June inflation cooling to 3.5% with a sharp pullback in gasoline prices and a softer headline consumer price index has turned the spotlight back on interest rate expectations and housing costs. For residential housing and real estate stocks, even small changes in inflation and energy prices can affect borrowing costs, construction budgets, and buyer confidence. This article looks at how this latest inflation print and the move in energy and housing components could matter for larger, housing...

With inflation trends diverging across regions, central banks rethinking interest rate paths and energy prices keeping markets on edge, many investors are looking for growth stories that are closely aligned with management’s own interests. That is where the Fast Growing Stocks With High Insider Ownership screener comes in. It highlights companies where insiders have significant skin in the game and analysts see room for further expansion. This article introduces three stocks from the screener...

Repligen stock is coming off a mixed five year stretch, with the share price down 27.3% over that period, while current valuation checks send a cautious signal that the stock is not obviously cheap or excessively stretched around its estimated intrinsic value from a Discounted Cash Flow (DCF) view. Over five years, Repligen shares have declined 27.3%. This asks investors to judge whether the current price fairly reflects what the business can deliver next. Expectations for Repligen’s ability...

United Community Banks recently entered the spotlight as analysts projected a year-over-year earnings increase and higher revenues for the June 2026 quarter, ahead of its July 21 earnings release. An interesting angle is that expectations for another potential earnings beat are partly anchored in the company’s history of outperforming consensus EPS estimates and its current analyst ranking. We’ll now explore how the expectation of higher quarterly earnings and revenues could influence...

Earlier this month, DexCom, Inc. reported that Health Canada authorized its Dexcom G7 15 Day Continuous Glucose Monitoring System for adults with diabetes, extending sensor wear to 15.5 days with best-in-class 8.0% MARD accuracy and integrated app-based data sharing. This longer-wear, high-accuracy CGM could strengthen DexCom’s position in Canada by improving convenience, reducing sensor waste, and deepening digital health integration for patients and clinicians. We’ll now examine how Health...

Earlier this week, United Airlines announced a new United Economy Plus row on its upcoming Airbus A321XLRs, featuring an open middle seat with a shared table, larger 4K screens, and expanded premium seating, with domestic flights on the aircraft set to begin later this year and international routes by early 2027. The move positions United as the only U.S. carrier offering this type of extra-space Economy Plus configuration, reinforcing its push to differentiate through premium-leaning...

Landstar System (LSTR) recently entered into a Third Amended and Restated Credit Agreement that refreshes its revolving credit facility and covenant package, giving investors new information to assess balance sheet flexibility and risk controls. See our latest analysis for Landstar System. At a share price of $207.81, Landstar System has seen the share price fall 1.70% over the last day but rise 21.21% across 90 days, with a 1 year total shareholder return of 57.60%. This suggests momentum...

In recent days, Autodesk has drawn renewed attention for its ongoing transition to a cloud-based subscription model, which is emphasizing steadier recurring revenue and tighter integration across its software portfolio. This shift has prompted fresh debate about whether the company’s current fundamentals and risk profile are being fully reflected in its overall valuation metrics. We’ll now examine how this renewed focus on Autodesk’s subscription-driven recurring revenue reshapes the...

Futu Holdings has had a mixed share price record, with the stock up 119.4% over the past three years but down sharply over the last year, while current valuation checks and the intrinsic value estimate from the Excess Returns model both suggest the stock trades at a discount to its estimated worth. A 119.4% gain over three years points to a stock that has already rewarded patient holders, even though more recent returns have been weaker. The launch of the Moomoo Engine can support the long...

Mettler-Toledo International (MTD) stock has caught investor attention recently after its latest trading update, with the share price at $1,316.55 and returns over the past month and past 3 months drawing closer scrutiny. See our latest analysis for Mettler-Toledo International. Recent trading has been strong for Mettler-Toledo International, with a 7 day share price return of 5.41% and a 30 day share price return of 14.04%. However, the year to date share price return is down 6.72% while the...

Mohawk Industries (MHK) has been drawing fresh attention after recent price moves, with the stock last closing at $111.51. Investors are weighing this against the company’s current valuation, profitability, and mixed multi year return profile. See our latest analysis for Mohawk Industries. Recent trading around Mohawk Industries has been relatively firm, with a 7 day share price return of 3.71% and a 90 day share price return of 9.16%. However, the 5 year total shareholder return has declined...

Kestra Medical Technologies (KMTS) shares are in focus after the company paired detailed fiscal 2026 results with fresh 2027 revenue guidance and a new multi tranche term loan facility that reshapes its funding profile. See our latest analysis for Kestra Medical Technologies. Kestra Medical Technologies’ latest earnings, 2027 revenue guidance and new term loan arrived after a choppy stretch, with a 1-day share price return of 1.8% and a 7-day share price return that declined 8.2%. However, a...

Axsome Therapeutics reported that the U.S. FDA has accepted its New Drug Application for AXS-12 to treat cataplexy in patients with narcolepsy. The filing includes a target FDA decision date, with the agency indicating that no advisory committee meeting is planned for the review. For Axsome Therapeutics, ticker NasdaqGM:AXSM, the FDA's acceptance of the AXS-12 NDA comes as the stock trades at $237.53. The company has seen strong share performance over longer horizons, with the stock up...

Recent analyst actions around Patterson-UTI Energy (PTEN), including an upgrade from Piper Sandler and a reiterated positive outlook from Susquehanna, have put the stock back on the radar as drilling activity indicators continue to attract attention. See our latest analysis for Patterson-UTI Energy. Against this backdrop, Patterson-UTI Energy’s share price has pulled back 7.69% over the past 30 days. It still shows a 52.09% year-to-date share price return and a 74.48% total shareholder return...

BankUnited Inc. recently opened a new full-service branch in Tampa’s Westshore district and plans to add a St. Petersburg branch after establishing a downtown Tampa corporate office, underscoring its expanded footprint in the region. These moves, coupled with the hiring of veteran banker Chad Loar to lead commercial banking across key states, point to a coordinated push to deepen commercial relationships in Florida and other core markets. We’ll now explore how the Florida branch expansion,...

Tariff refunds are suddenly sending billions of dollars back to import-heavy companies, turning a legal ruling into what some are calling an accidental stimulus. For consumer staples and retailers, that unexpected cash can mean more room to manage prices, offset higher input costs, or reinvest in their operations. This article looks at 3 stocks exposed to the Supreme Court tariff decision, all drawn from a screener focused on large, financially healthy consumer-focused companies that could be...

Bank of America (BAC) has reported another solid quarter, with Q2 2026 revenue at US$30.2b and basic EPS of US$1.22, supported by net income of US$8.7b as the stock trades around US$61.59. Over the last few quarters, revenue has moved from US$24.9b in Q2 2025 to US$30.2b in Q2 2026, while basic EPS has ranged from US$0.90 to US$1.22, helping trailing twelve month EPS reach US$4.40. For investors, a key consideration now is how durable these earnings and margins appear as management balances...

In recent weeks, JLL’s Capital Markets group arranged a US$352 million floating-rate SASB refinancing for 425 Lexington Avenue in Midtown Manhattan and secured a US$275 million refinancing plus US$57 million mezzanine loan for Chicago’s NEMA multifamily tower, while the firm also elevated Maroun Deeb to lead Project & Development Services across the Middle East and Africa. Combined with JLL’s new AI-focused workforce study, these transactions and leadership changes highlight the company’s...

Kraft Heinz recently paused its planned business separation and, instead, redirected management attention toward pricing, innovation, brand building, and operational improvements to respond to weak volumes, private‑label competition, and ongoing cost pressures tied to crude oil. This shift signals management’s choice to concentrate on fixing core execution issues rather than pursuing complex portfolio reshaping that could add further disruption. Next, we’ll examine how Kraft Heinz’s decision...

In July 2026, First American Data & Analytics announced that its nationwide, GIS-ready property intelligence datasets, including parcel boundaries, ownership, addresses, building footprints, sales, tax and valuation data, are now available directly within Esri’s ArcGIS ecosystem via web feature layers and other delivery options. This integration links parcels, addresses, structures, ownership and transaction activity through a common property identifier inside ArcGIS workflows, potentially...

How Otter Tail Stock Looks After Recent Performance Otter Tail (OTTR) has drawn fresh attention after a period of steady share performance, including a recent close at $90.18. This has prompted investors to reassess the utility and manufacturing company’s mix of businesses and earnings profile. See our latest analysis for Otter Tail. The recent move to $90.18 comes on top of a steady trend, with a 10.72% year to date share price return and a 21.54% total shareholder return over the past year...

Philip Morris International recently received U.S. Food and Drug Administration authorization to commercialize its ZYN smoke-free nicotine pouches as modified risk tobacco products, the first nicotine pouch brand to gain this designation, after submitting extensive scientific evidence that switching completely from cigarettes to ZYN reduces exposure to harmful chemicals linked to major smoking-related diseases. This decision gives Philip Morris International a unique regulatory position in...

Intel (INTC) is back in focus after announcing a US$5.7b expansion of its Leixlip, Ireland campus, alongside new AI partnerships, including Ultralytics YOLO models optimized for Intel OpenVINO across its processor portfolio. See our latest analysis for Intel. These AI moves land at a time when Intel’s share price has cooled in the short term, with a 1-day share price return of 4.43% and 30-day share price return of 19.45% declines, even as its year-to-date share price return of 161.53% and...

In July 2026, Elanco Animal Health granted deferred stock units to CEO Jeffrey N. Simmons, CFO Robert M. VanHimbergen, and officer Rajeev A. Modi under its Executive Deferral and Stock Match Plan, with units settling in cash or shares after employment ends or at a future specified date. Alongside these insider awards, fresh analyst commentary highlighting Elanco’s recent earnings surprises and positive indicators for another outperformance has sharpened investor focus on the company’s...